1. | | No longer recruiting | Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma Condition: Lymphoma |
2. | | Recruiting | Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
3. | | No longer recruiting | Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma Conditions: stage III multiple myeloma; refractory plasma cell neoplasm |
4. | | Recruiting | Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation Condition: adult non-Hodgkin's lymphoma |
5. | | No longer recruiting | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer |
6. | | Completed | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
7. | | No longer recruiting | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Conditions: AIDS-related primary CNS lymphoma; primary central nervous system lymphoma |
8. | | Recruiting | Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer |
9. | | Recruiting | Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
10. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer |
11. | | Suspended | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
12. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
13. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
14. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
15. | | No longer recruiting | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease Conditions: HIV-associated Hodgkin's disease; AIDS-Related Lymphoma |
16. | | Recruiting | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma Conditions: AIDS-related diffuse large cell lymphoma; AIDS-related diffuse mixed cell lymphoma; AIDS-related diffuse small cleaved cell lymphoma; ... |
17. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, or Multiple Myeloma Conditions: recurrent adult lymphoblastic lymphoma; recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ... |
18. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer |
19. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer |
20. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
21. | | Completed | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
22. | | Completed | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia Conditions: adult acute myelomonocytic leukemia (M4); adult acute differentiated monocytic leukemia (M5b); recurrent adult acute lymphocytic leukemia; ... |
23. | | Recruiting | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
24. | | No longer recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; ... |
25. | | No longer recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Donor Lymphocyte Infusion in Treating Women With Stage IV Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
26. | | Recruiting | Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer Conditions: anaplastic thyroid cancer; recurrent thyroid cancer |
27. | | No longer recruiting | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
28. | | No longer recruiting | Compassionate Use Program of Campath-1H in Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia Conditions: refractory chronic lymphocytic leukemia; Prolymphocytic Leukemia |
29. | | Recruiting | Cyclophosphamide With or Without Rituximab and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Condition: adult non-Hodgkin's lymphoma |
30. | | Recruiting | Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer Conditions: stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer |
31. | | No longer recruiting | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer Conditions: stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
32. | | Recruiting | Donor Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
33. | | Suspended | Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer; Male Breast Cancer |
34. | | Recruiting | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer |
35. | | No longer recruiting | Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed or Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome Condition: Leukemia |
36. | | Recruiting | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
37. | | Recruiting | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
38. | | No longer recruiting | Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas |
39. | | Completed | Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia After Stem Cell Transplantation Conditions: recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia |
40. | | Recruiting | Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Conditions: adult brain tumor; adult non-Hodgkin's lymphoma; adult solid tumor |
41. | | Recruiting | GW786034 in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
42. | | Completed | HER-2 Protein Vaccine in Treating Women With Breast Cancer Conditions: stage IV breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
43. | | Recruiting | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
44. | | Completed | Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure Conditions: adult solid tumor; central nervous system cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer |
45. | | Recruiting | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer Condition: anaplastic thyroid cancer |
46. | | Recruiting | Induction Therapy Using Cisplatin, Etoposide, and Radiation Therapy Followed By Consolidation Therapy Using Gemcitabine With or Without Docetaxel in Treating Patients With Unresectable Stage IIIB Non-Small Cell Lung Cancer Condition: Non-small cell lung cancer |
47. | | No longer recruiting | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer |
48. | | Completed | Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
49. | | No longer recruiting | Letrozole With or Without CCI-779 in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Conditions: stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer |
50. | | No longer recruiting | Letrozole With or Without Tipifarnib in Treating Women With Locally Advanced, Locally Recurrent, or Metastatic Breast Cancer Condition: Breast Cancer |